Choroidal and Retinal Thickness Following Strabismus Surgery
NCT ID: NCT04285177
Last Updated: 2020-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2020-02-15
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Choroidal Thickness Using Optical Coherence Tomography
NCT06272851
A Prospective Study of Traumatic Eye Injuries in the Period From January 2022 to June 2022 in Sohag University Hospitals
NCT05164588
Changes of Macular Vasculature After Uncomplicated Phacoemulsification Surgery Using Optical Coherence Tomography Angiography
NCT04594603
Choroidal Thickness in Myopes by SSOCT
NCT03542448
Visual Outcome of Traumatic Posterior Segment Complications
NCT04521283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Duration: February 2020 till May 2020 and may be extended
* The study will include 30 patients who suffer from esotropia or exotropia, inferior oblique (IO) over-action with or without any other type of horizontal deviation
Pre-operative measurement of the macular and choroidal thickness by Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT).
Post-operative measurement: First day, first week, one month then 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Horizontal muscle surgery
Patients suffering from esotropia or exotropia, will have medial/lateral rectus recession/resection
Strabismus surgery
Resection or recession of the medial or lateral rectus muscle, or inferior oblique myectomy
Patients with Inferior Oblique Overaction
Will undergo inferior Oblique Myectomy
Strabismus surgery
Resection or recession of the medial or lateral rectus muscle, or inferior oblique myectomy
Patients with combined horizontal and oblique muscle surgery
Having combined surgery
Strabismus surgery
Resection or recession of the medial or lateral rectus muscle, or inferior oblique myectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strabismus surgery
Resection or recession of the medial or lateral rectus muscle, or inferior oblique myectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal ocular examination findings
* No medical or family history of retinal disease, glaucoma or diabetes mellitus.
Exclusion Criteria
* Patients with sensory or restrictive strabismus or neurological disease
* Preoperative retinal or macular pathology
* Patient who is unable to cooperate to do OCT scanning
7 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heba Shafik
Clinical Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharif Y El Emam, MD
Role: PRINCIPAL_INVESTIGATOR
Tanta University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University Hospital
Tanta, Gharbia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TUORU003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.